NCT05706935View on ClinicalTrials.gov

MeMed BV® Test Evaluation in Adult Emergency Department Patients

CompletedOBSERVATIONAL
Enrollment

111

Participants

Timeline

Start Date

February 6, 2023

Primary Completion Date

July 31, 2023

Study Completion Date

January 31, 2024

Conditions
Respiratory InfectionRespiratory Infections in Old AgeRespiratory Infection VirusRespiratory Infection Bacterial
Interventions
DIAGNOSTIC_TEST

MeMed BV® test

The MeMed BV® test is an automated semiquantitative immunoassay that measures three nonmicrobial (host) proteins (TRAIL, IP-10, and CRP) in serum samples and is intended for use in conjunction with clinical assessments and other laboratory findings as an aid to differentiate bacterial from viral infection.

Trial Locations (1)

53792

University of Wisconsin, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER